CATALYST PHARMACEUTICALS, INC. et al v. TEVA PHARMACEUTICALS, INC. et al
Counter Defendant: CATALYST PHARMACEUTICALS, INC. and SERB SA
Counter Claimant: TEVA PHARMACEUTICALS, INC., TEVA PHARMACEUTICALS USA, INC. and TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Case Number: 2:2023cv01190
Filed: March 1, 2023
Court: US District Court for the District of New Jersey
Presiding Judge: Jose R Almonte
Referring Judge: Madeline Cox Arleo
Nature of Suit: Patent - Abbreviated New Drug Application(ANDA)
Cause of Action: 35 U.S.C. § 271 Patent Infringement
Jury Demanded By: None
Docket Report

This docket was last retrieved on April 24, 2023. A more recent docket listing may be available from PACER.

Date Filed Document Text
April 24, 2023 Filing 30 ANSWER to Counterclaim by CATALYST PHARMACEUTICALS, INC., SERB SA.(CHEVALIER, CHARLES)
April 20, 2023 Opinion or Order Filing 29 TEXT ORDER: The initial scheduling conference set for April 25, 2023 is adjourned to May 1, 2023, at 10:30 a.m.. So Ordered by Magistrate Judge Jose R. Almonte on 4/20/2023. (akw)
April 20, 2023 Filing 28 Joint Discovery Plan by All Plaintiffs. (Attachments: #1 Text of Proposed Order)(CHEVALIER, CHARLES)
April 17, 2023 Filing 27 STIPULATION OF DISMISSAL OF COMPLAINT AS TO DEFENDANT TEVA PHARMACEUTICAL INDUSTRIES LTD. AND AMENDMENT OF CAPTION. Signed by Judge Madeline Cox Arleo on 4/17/2023. (mxw)
April 5, 2023 Filing 26 AO120 Patent/Trademark Form filed. (Attachments: #1 Complaint) (mxw)
April 5, 2023 Opinion or Order Filing 25 ORDER granting #24 Motion for GEORGE C. LOMBARDI, ESQ., IVAN M. POULLAOS, ESQ., ALISON KING, ESQ., and BRIAN L. OGARA, ESQ. to Appear Pro Hac Vice. Signed by Magistrate Judge Jose R. Almonte on 4/5/2023. (mxw)
April 5, 2023 Pro Hac Vice counsel, ADAM C. LAROCK, JOSEPHINE KIM, LAUREN A. WATT, CHRISTOPHER M. GALLO, PHD, JOSEPH H. KIM, ALEXANDER ALFANO, DAVIN B. GUINN and RYAN E. CONKIN, have been added to receive Notices of Electronic Filing. Pursuant to L.Civ.R. 101.1, only local counsel are entitled to sign and file papers, enter appearances and receive payments on judgments, decrees or orders. (mxw)
April 4, 2023 Filing 24 MOTION for Leave to Appear Pro Hac Vice by TEVA PHARMACEUTICAL INDUSTRIES LIMITED, TEVA PHARMACEUTICALS USA, INC.. (Attachments: #1 Declaration Weider Declaration, #2 Declaration Alison King Declaration ISO of Pro Hac Vice Admission, #3 Declaration Lombardi Declaration ISO of Pro Hac Vice Admission, #4 Declaration O'Gara Declaration ISO of Pro Hac Vice Admission, #5 Declaration Poullaos Declaration ISO of Pro Hac Vice Admission, #6 Text of Proposed Order Proposed Order)(WEIDER, DOUGLAS)
April 4, 2023 Filing 23 Notice of Request by Pro Hac Vice Ryan E. Conkin to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14219940.) (CHEVALIER, CHARLES)
April 4, 2023 Filing 22 Notice of Request by Pro Hac Vice Davin B. Guinn to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14219934.) (CHEVALIER, CHARLES)
April 4, 2023 Filing 21 Notice of Request by Pro Hac Vice Alexander Alfano to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14219932.) (CHEVALIER, CHARLES)
April 4, 2023 Filing 20 Notice of Request by Pro Hac Vice Joseph H. Kim to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14219931.) (CHEVALIER, CHARLES)
April 4, 2023 Filing 19 Notice of Request by Pro Hac Vice Christopher M. Gallo, Ph.D. to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14219927.) (CHEVALIER, CHARLES)
April 4, 2023 Filing 18 Notice of Request by Pro Hac Vice Lauren A. Watt to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14219919.) (CHEVALIER, CHARLES)
April 4, 2023 Filing 17 Notice of Request by Pro Hac Vice Josephine Kim to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14219915.) (CHEVALIER, CHARLES)
April 4, 2023 Filing 16 Notice of Request by Pro Hac Vice Adam C. LaRock to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14219910.) (CHEVALIER, CHARLES)
April 3, 2023 Opinion or Order Filing 15 ORDER granting #12 Motion for Leave to Appear Pro Hac Vice as to ADAM C. LAROCK, ESQ., JOSEPHINE KIM, ESQ., LAUREN A. WATT, ESQ., CHRISTOPHER M. GALLO, PH.D., ESQ., JOSEPH H. KIM, ALEXANDR ALFANO, ESQ., DAVIN B. GUINN, ESQ., and RYAN E. CONKIN, ESQ. Signed by Magistrate Judge Jose R. Almonte on 4/3/2023. (lag, )
April 3, 2023 Filing 14 Corporate Disclosure Statement by TEVA PHARMACEUTICAL INDUSTRIES LIMITED, TEVA PHARMACEUTICALS USA, INC., TEVA PHARMACEUTICALS, INC. identifying Teva Ltd. as Corporate Parent.. (WEIDER, DOUGLAS)
April 3, 2023 Filing 13 ANSWER to Complaint , COUNTERCLAIM against All Plaintiffs by All Defendants.(WEIDER, DOUGLAS)
April 3, 2023 Filing 12 Consent MOTION for Leave to Appear Pro Hac Vice by CATALYST PHARMACEUTICALS, INC., SERB SA. (Attachments: #1 Declaration of Charles H. Chevalier, #2 Declaration of Adam C. LaRock, #3 Declaration of Josephine Kim, #4 Declaration of Lauren A. Watt, #5 Declaration of Christopher M. Gallo, Ph.D., #6 Declaration of Joseph H. Kim, #7 Declaration of Alexander Alfano, #8 Declaration of Davin B. Guinn, #9 Declaration of Ryan E. Conkin, #10 Text of Proposed Order)(CHEVALIER, CHARLES)
March 31, 2023 Filing 11 STIPULATION of Dismissal of Complaint and Amendment of Caption by TEVA PHARMACEUTICAL INDUSTRIES LIMITED, TEVA PHARMACEUTICALS USA, INC., TEVA PHARMACEUTICALS, INC.. (WEIDER, DOUGLAS)
March 27, 2023 Filing 10 NOTICE of Appearance by DENNIES VARUGHESE on behalf of All Plaintiffs (VARUGHESE, DENNIES)
March 23, 2023 Filing 9 NOTICE of Appearance by CHRISTINE A. GADDIS on behalf of CATALYST PHARMACEUTICALS, INC., SERB SA (GADDIS, CHRISTINE)
March 16, 2023 Filing 8 SUMMONS Returned Executed by CATALYST PHARMACEUTICALS, INC., SERB SA. TEVA PHARMACEUTICAL INDUSTRIES LIMITED served on 3/13/2023, answer due 4/3/2023. (CHEVALIER, CHARLES)
March 16, 2023 Filing 7 SUMMONS Returned Executed by CATALYST PHARMACEUTICALS, INC., SERB SA. TEVA PHARMACEUTICALS USA, INC. served on 3/13/2023, answer due 4/3/2023. (CHEVALIER, CHARLES)
March 16, 2023 Filing 6 SUMMONS Returned Executed by CATALYST PHARMACEUTICALS, INC., SERB SA. TEVA PHARMACEUTICALS, INC. served on 3/13/2023, answer due 4/3/2023. (CHEVALIER, CHARLES)
March 8, 2023 Opinion or Order Filing 5 LETTER ORDER Pursuant to Local Civil Rule 16.1. On 4/25/2023 at 3:30 PM there shall be an Initial Scheduling Conference before Magistrate Judge Jose R. Almonte, etc. Signed by Magistrate Judge Jose R. Almonte on 3/8/2023. (smf)
March 2, 2023 Magistrate Judge Jose R. Almonte added. (ps)
March 1, 2023 Filing 4 SUMMONS ISSUED as to TEVA PHARMACEUTICAL INDUSTRIES LIMITED, TEVA PHARMACEUTICALS USA, INC., TEVA PHARMACEUTICALS, INC.. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (mxw, )
March 1, 2023 Filing 3 Corporate Disclosure Statement by SERB SA identifying NONE as Corporate Parent.. (CHEVALIER, CHARLES)
March 1, 2023 Filing 2 Corporate Disclosure Statement by CATALYST PHARMACEUTICALS, INC. identifying NONE as Corporate Parent.. (CHEVALIER, CHARLES)
March 1, 2023 Filing 1 COMPLAINT against TEVA PHARMACEUTICAL INDUSTRIES LIMITED, TEVA PHARMACEUTICALS USA, INC., TEVA PHARMACEUTICALS, INC. ( Filing and Admin fee $ 402 receipt number ANJDC-14125181), filed by CATALYST PHARMACEUTICALS, INC., SERB SA. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Civil Cover Sheet, #8 Certification Pursuant to Local Civil Rule 11.2)(CHEVALIER, CHARLES)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the New Jersey District Court's Electronic Court Filings (ECF) System

Search for this case: CATALYST PHARMACEUTICALS, INC. et al v. TEVA PHARMACEUTICALS, INC. et al
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Counter defendant: CATALYST PHARMACEUTICALS, INC.
Represented By: CHARLES H. CHEVALIER
Represented By: DENNIES VARUGHESE
Represented By: CHRISTINE A. GADDIS
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Counter defendant: SERB SA
Represented By: CHARLES H. CHEVALIER
Represented By: DENNIES VARUGHESE
Represented By: CHRISTINE A. GADDIS
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Counter claimant: TEVA PHARMACEUTICALS, INC.
Represented By: DOUGLAS ROBERT WEIDER
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Counter claimant: TEVA PHARMACEUTICALS USA, INC.
Represented By: DOUGLAS ROBERT WEIDER
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Counter claimant: TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Represented By: DOUGLAS ROBERT WEIDER
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?